Tatva Chintan Pharma Chem Limited

NSEI:TATVA 주식 보고서

시가총액: ₹25.8b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Tatva Chintan Pharma Chem 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Chintan Shah

최고 경영자

₹16.5m

총 보상

CEO 급여 비율30.8%
CEO 임기28yrs
CEO 소유권23.8%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간15.7yrs

최근 관리 업데이트

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

CEO 보상 분석

Chintan Shah 의 보수는 Tatva Chintan Pharma Chem 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

₹304m

Dec 31 2023n/an/a

₹377m

Sep 30 2023n/an/a

₹459m

Jun 30 2023n/an/a

₹452m

Mar 31 2023₹17m₹5m

₹455m

Dec 31 2022n/an/a

₹460m

Sep 30 2022n/an/a

₹572m

Jun 30 2022n/an/a

₹825m

Mar 31 2022₹17m₹5m

₹959m

Dec 31 2021n/an/a

₹995m

Sep 30 2021n/an/a

₹976m

Jun 30 2021n/an/a

₹687m

Mar 31 2021₹14mn/a

₹523m

Mar 31 2020₹14mn/a

₹378m

Mar 31 2019₹14mn/a

₹205m

보상 대 시장: Chintan 의 총 보상 ($USD 197.74K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 267.13K ).

보상과 수익: Chintan 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Chintan Shah (50 yo)

28yrs

테뉴어

₹16,503,252

보상

Mr. Chintan Nitinkumar Shah is the Managing Director and Chairman at Tatva Chintan Pharma Chem Limited and its Executive Director since June 12, 1996. He holds a bachelor’s degree in engineering, with a sp...


이사회 구성원

이름위치테뉴어보상소유권
Chintan Shah
Chairman & MD28yrs₹16.50m23.84%
₹ 6.2b
Ajaykumar Patel
Whole Time Director28yrs₹16.50m24.01%
₹ 6.2b
Shekhar Somani
Whole Time Director28yrs₹16.50m24%
₹ 6.2b
Manher Desai
Non Executive Independent Director3.3yrs₹230.00k데이터 없음
Subhash Patel
Non Executive Independent Director3.3yrs₹250.00k데이터 없음
Avani Umatt
Non Executive Independent Director3.3yrs₹180.00k데이터 없음

15.7yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 이사회: TATVA 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 15.7 년).